摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-苄基-2,4-二氨基嘧啶 | 7319-45-1

中文名称
5-苄基-2,4-二氨基嘧啶
中文别名
——
英文名称
2,4-diamino-5-benzylpyrimidine
英文别名
2,4-diamino-5-benzyl pyrimidine;5-benzyl-pyrimidine-2,4-diamine;5-Benzyl-pyrimidin-2,4-diyldiamin;2,4-diamino 5-benzyl pyrimidine;5-Benzyl-2,4-diaminopyrimidine;5-benzylpyrimidine-2,4-diamine
5-苄基-2,4-二氨基嘧啶化学式
CAS
7319-45-1
化学式
C11H12N4
mdl
MFCD09877845
分子量
200.243
InChiKey
XHPZVBGIPQQTQW-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    194-196 °C(Solv: ethanol (64-17-5))
  • 沸点:
    459.7±37.0 °C(Predicted)
  • 密度:
    1.252±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.6
  • 重原子数:
    15
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.09
  • 拓扑面积:
    77.8
  • 氢给体数:
    2
  • 氢受体数:
    4

SDS

SDS:db7737ffbfae6412230557f776aa4933
查看

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] PYRIMIDINE DERIVATIVES USED AS ITK INHIBITORS<br/>[FR] DÉRIVÉS DE PYRIMIDINE UTILISÉS COMME INHIBITEURS DE LTK
    申请人:GLAXO GROUP LTD
    公开号:WO2010106016A1
    公开(公告)日:2010-09-23
    The invention is directed to certain novel compounds. Specifically, the invention is directed to compounds of formula (I): and salts thereof. The compounds of the invention are inhibitors of kinase activity, in particular ltk activity.
    本发明涉及某些新颖化合物。具体而言,本发明涉及以下公式(I)的化合物及其盐类。发明的化合物是激酶活性的抑制剂,特别是ltk活性的抑制剂。
  • [EN] METHODS AND COMPOSITIONS FOR TREATING DISEASES AND CONDITIONS<br/>[FR] MÉTHODES ET COMPOSITIONS POUR LE TRAITEMENT DE MALADIES ET D'AFFECTIONS
    申请人:AFFERENT PHARMACEUTICALS INC
    公开号:WO2016004358A1
    公开(公告)日:2016-01-07
    Provided herein include methods and compositions for treating diseases or conditions. In some embodiments provided are methods for treating one or more diseases or conditions selected from the group consisting of hypertension, heart failure, dyspnea, and sleep apnea. In certain embodiments provided are methods that include administering a compound of formula (I) as disclosed herein. In some embodiments provided are methods that include administering a P2X3 and/or a P2X2/3 receptor antagonist.
    本文提供了用于治疗疾病或症状的方法和组合物。在某些实施例中,提供了治疗高血压、心力衰竭、呼吸困难和睡眠呼吸暂停等一种或多种疾病或症状的方法。在特定实施例中,提供了包括根据本文披露的化合物(I)的方法。在某些实施例中,提供了包括给予P2X3和/或P2X2/3受体拮抗剂的方法。
  • Benzofuran derivatives and their use as antibacterial agents
    申请人:——
    公开号:US20040034047A1
    公开(公告)日:2004-02-19
    The invention relates to novel benzofuran derivatives and their use as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including processes for the preparation of the compounds, pharmaceutical compositions containing one or more of those compounds and especially their use as anti-infectives.
    该发明涉及新型苯并呋喃衍生物及其作为药物成分在制备药物组合物中的用途。该发明还涉及相关方面,包括制备化合物的过程、含有其中一种或多种化合物的药物组合物,特别是它们作为抗感染剂的用途。
  • [EN] BENZOFURAN DERIVATIVES AND THEIR USE IN THE TREATMENT OF MICROBIAL INFECTIONS<br/>[FR] DERIVES DE BENZOFURANE ET LEUR UTILISATION DANS LE TRAITEMENT D'INFECTIONS MICROBIENNES
    申请人:ARPIDA AG
    公开号:WO2005005418A1
    公开(公告)日:2005-01-20
    The invention relates to new benzofuran derivatives of the general formula I and their use as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including processes for the preparation of the compounds, pharmaceutical compositions containing one or more of those compounds and especially their use as anti-infectives.
    本发明涉及一种新的苯并呋喃衍生物,其一般式为I,并且它们作为制备药物组成中的活性成分的用途。本发明还涉及相关方面,包括制备化合物的过程,含有这些化合物中的一种或多种的药物组合物,特别是它们作为抗感染剂的用途。
  • Processes for preparing tri-heterocyclic substituted methanes and their conversion into further intermediates useful in the preparation of pharmacologically active compounds
    申请人:THE WELLCOME FOUNDATION LIMITED
    公开号:EP0001633A1
    公开(公告)日:1979-05-02
    The present invention provides a process for preparing useful chemical intermediates, tri-heterocyclic substituted methanes, and their conversion into further intermediates useful in the preparation of pharmacologically active compounds, such as trimethoprim and allopurinol.
    本发明提供了一种制备有用的化学中间体,三杂环取代甲烷及其转化为进一步中间体的过程,这些中间体可用于制备药理活性化合物,如曲唑酮和痛风宁。
查看更多